Scholarlink

<p>Inflammatory bowel disease (IBD) is a chronic relapsing disorder primarily driven by the self-amplified vicious cycle of colonic barrier disruption-inflammation (VCBI). Especially, these pathogenic mediators of the VCBI often exist in different phases, such as ROS (inflammatory mediators) in the liquid phase and H<sub>2</sub>S (colonic barrier disruptors) in the gas phase, poses a formidable challenge to their concurrent elimination. Herein, a gas-liquid biphasic nanocleaner (GLBN) is developed for breaking the self-amplified VCBI in IBD by concurrently scavenging the pathogenic factors derived from both liquid and gaseous phases. Benefiting from its high specific surface area, superior intrinsic activity, and ultrasmall size, GLBN provides abundant adsorption and active sites, thereby exhibiting highly efficient H<sub>2</sub>S-capturing capability with a scavenging efficiency of 88.6% and attenuating H<sub>2</sub>S-mediated colonic barrier dysfunction. Meanwhile, owing to its highly efficient ROS-scavenging capacity, with respective scavenging efficiencies of 84.3% for H<sub>2</sub>O<sub>2</sub> and 82.7% for •O<sub>2</sub><sup>−</sup>, GLBN effectively suppresses inflammation and promotes macrophage repolarization from the M1 toward the M2 phenotype. Moreover, density function Sal theory (DFT) calculations attribute the biphasic scavenging capabilities to heterogeneous facets and metal-sulfur bonding. Consequently, highly efficient therapy of IBD is achieved in a mouse model. Our study marks a critical breakthrough in the therapeutic application of biphasic scavenging nanozymes for inflammatory diseases triggered by multiphase pathogenic factors.</p> Graphical Abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

A gas-liquid biphasic nanocleaner for breaking the self-amplified vicious cycle of barrier disruption-inflammation in inflammatory bowel disease

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年5月24日

查看全文
  • Haibin Wu,
  • Jixiang Zhang,
  • Xinqing Huang,
  • Bo Zhang,
  • Yuting Xie,
  • Qingyu Li,
  • Li Yang,
  • Weiqi Wu,
  • Ziying Zheng,
  • Ziyan Huang,
  • Fanru Gao,
  • Zhongqing Cai,
  • Jiahe Chen,
  • Guohuan Zeng,
  • Daishun Ling,
  • Guang Liang,
  • Qian Chen

摘要

Inflammatory bowel disease (IBD) is a chronic relapsing disorder primarily driven by the self-amplified vicious cycle of colonic barrier disruption-inflammation (VCBI). Especially, these pathogenic mediators of the VCBI often exist in different phases, such as ROS (inflammatory mediators) in the liquid phase and H2S (colonic barrier disruptors) in the gas phase, poses a formidable challenge to their concurrent elimination. Herein, a gas-liquid biphasic nanocleaner (GLBN) is developed for breaking the self-amplified VCBI in IBD by concurrently scavenging the pathogenic factors derived from both liquid and gaseous phases. Benefiting from its high specific surface area, superior intrinsic activity, and ultrasmall size, GLBN provides abundant adsorption and active sites, thereby exhibiting highly efficient H2S-capturing capability with a scavenging efficiency of 88.6% and attenuating H2S-mediated colonic barrier dysfunction. Meanwhile, owing to its highly efficient ROS-scavenging capacity, with respective scavenging efficiencies of 84.3% for H2O2 and 82.7% for •O2−, GLBN effectively suppresses inflammation and promotes macrophage repolarization from the M1 toward the M2 phenotype. Moreover, density function Sal theory (DFT) calculations attribute the biphasic scavenging capabilities to heterogeneous facets and metal-sulfur bonding. Consequently, highly efficient therapy of IBD is achieved in a mouse model. Our study marks a critical breakthrough in the therapeutic application of biphasic scavenging nanozymes for inflammatory diseases triggered by multiphase pathogenic factors.

Graphical Abstract